HERBAL COMPOSITION dhl Lung-KR++ Capsule FOR THE PREVENTIVE APPLICATION AGAINST COVID-19.
COVID-19 also known as Coronavirus has affected more than 87,000 people across world. It has flu like symptoms which includes running nose, cough, fever, body pain and breathlessness. Lungs are exposed to approximately 7000 litres of air every day. The viruses being air- borne are inhaled through the nose and reaches the lungs where it attacks the cell machinery and starts the replication thus lowering the immunity of the host and causing flu-like symptoms in the body. The breathlessness caused by the virus is alsodue to the loss of the lining of the alveolar cells.
Herbs and plants naturally contain many active chemicals and thus drugs derived from such sources can have multiple health benefits when administered to patients. Due to the presence of multiple active compounds in phytomedicines, they are an ideal candidate for treating conditions with a variety of symptoms such as inflammatory diseases which affect multiple systems(Clarke et al., 2015).
Herbal medicine-derived natural products can be considered as an alternative therapeutic potential for respiratory diseases since several compounds showed anti-inflammatory effects inhibition different inflammatory mediators involved in respiratory diseases(Santana et al., 2016).
It is believed that the natural products derived from plants inhibit the pulmonary inflammation by the inhibition of the transcription of NF-κB to the nucleus, thus preventing the development of all the inflammatory processes triggered by allergen, cigarette smoke, virus, or bacteria. Therefore, herbal supplements can reduce the inflammatory cytokines release and oxidative stress. These effects together culminate with the improvement of lung function and with the reduction of pulmonary inflammation(Santana et al., 2016).
Most of the studies are pointing out the effects of natural products on the inhibition of NF-κB and MAPK pathways, besides the antioxidant effects associated with these products(Santana et al., 2016).
Dalmia Centre for Research and Development (DCRD), after many years of extensive research developed dhl Lung-KR++ capsules that are composed of phyto –constituents that are evidently proved to cure all respiratory problems. This formulation has undergone a randomized double blind, placebo -controlled study on patients under the watchful eyes of internationally recognized respiratory physicians who followed a peer reviewed ethically approved clinical protocol to assess the efﬁcacy of dhl Lung-KR++ in comparison to the modern medicines.
The unique blend of 14 herbs involved in dhl Lung-KR++ Capsules immunity and Prevention against corona virus to the person. It also acts as a bronchodilator, decongestant, anti -inﬂammatory and lung detoxiﬁer. According to the double-blind study using DCBT4567 – dhl Lung-KR++, it was found that the patients tested had signiﬁcant reduction (95% signiﬁcance) in dyspnoea, wheezing cough, expectoration, disability and sleep disturbances. It helps in eliminating the infection and regulating the allergic reactions (Suja et al., 2009). This has speciﬁc action on the mucosa of the respiratory tract and the muscular walls of the lungs that act as the airways.
It has an anti – inﬂammatory effect which reduces inﬂammation and congestion inside the lungs. Its continuous use reduces the damage on lungs and the muscular walls and brings out signiﬁcant reversal in their dysfunction.
1.Murali, P., Rajasekaran, S., Krishnarajasekar, O., Perumal, T., Nalini, K., Lakshmisubramanian, S. and Deivanayagam, C. (2006). Plant-Based Formulation for Bronchial Asthma: A Controlled Clinical Trial to Compare Its Efﬁcacy with Oral Salbutamol and Theophylline. Respiration, 73(4), pp.457-463.
2.Clarke, R., Lundy, F. and McGarvey, L. (2015). Herbal treatment in asthma and COPD –current evidence.Clinical Phytoscience, 1(1).
3.Santana, F., Pinheiro, N., Mernak, M., Righetti, R., Martins, M., Lago, J., Lopes, F., Tibério, I.and Prado, C. (2016). Evidences of Herbal Medicine-Derived Natural Products Effects in Inﬂammatory Lung Diseases. Mediators of Inﬂammation, 2016, pp.1-14.
4.Suja RS, Nair AM, Sujith S, Preethy J, Deepa AK. Evaluation of immunomodulatory potential of
Emblicaofﬁcinalis fruit pulp extract in mice. Indian J Anim Res. 2009;43:103–6.